AJP - Regu Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 284: R607-R610, 2003; doi:10.1152/ajpregu.00578.2002
0363-6119/03 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wetzel, K.
Right arrow Articles by Morano, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wetzel, K.
Right arrow Articles by Morano, I.
Vol. 284, Issue 2, R607-R610, February 2003

REPORT
Expression of smooth muscle MyHC B in blood vessels of hypertrophied heart in experimentally hypertensive rats

Katharina Wetzel1, Ovidiu Baltatu1, Benno Nafz2, Pontus B. Persson2, Hannelore Haase1, and Ingo Morano1,2

1 Max Delbrück Center for Molecular Medicine, 13122 Berlin-Buch; and 2 Johannes-Müller-Institute of Physiology, Humboldt-University, Medical Faculty (Charité), Berlin, Germany


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

We demonstrated recently a significantly lower fraction of cardiac precapillary arterioles that expressed smooth muscle myosin heavy chain (MyHC) B (SMB) in spontaneously hypertensive rats. To clarify whether this reduction of SMB expression is of genetic origin, we investigated SMB expression in cardiac precapillary arterioles of normotensive and experimentally hypertensive rats (one clip, one kidney or ANG II minipump). We observed similar SMB expression patterns in precapillary arterioles of experimentally hypertensive rats compared with normotensive controls. These observations suggest that the downregulation of SMB in spontaneously hypertensive rats is of genetic origin rather than an adaptive response to chronically enhanced blood pressure and cardiac hypertrophy.

hypertrophy; hypertension; myosin heavy chain


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

TYPE II MYOSIN, a hexamer composed of two myosin heavy chains (MyHCs), each associated with two types of light chains (MyLCs), is the molecular motor of all muscle cells. (17). At least seven different genes coding for MyHCs and seven genes coding for MyLCs exist (15, 20, 24). Splicing of exon 39 generates SM1 (204 kDa), and inclusion of exon 39 yields SM2 (200 kDa) (1, 10, 19, 21, 23, 27). Splicing of exon 5b generates the A forms; its inclusion generates the B forms (10, 19, 21, 23).

Smooth muscle MyHC B (SMB) revealed an approximately twofold higher actin-activated Mg2+-ATPase activity, attachment time (14), and actin filament movement velocity in the in vitro motility assay than smooth muscle MyHC A (SMA; Refs. 13, 22). Recently, an SMB knockout mouse model confirmed higher force generation and cross-bridge cycling kinetics of smooth muscle preparations in the presence of SMB (2).

The phasic smooth muscle tissue from the antrum region of the stomach (8), urinary bladder (11, 27, 28), esophageal body (25), intestine (27), trachea, and airway (16) contains predominantly the SMB isoform, whereas smooth muscle cells from myometrium (27), urethra (11), lower esophageal sphincter (25), fundus region of the stomach (8), the corpus cavernosum (7), aorta (6, 27), and vena cava (27) contain predominantly the SMA isoform. In contrast, precapillary arterioles expressed considerable amounts of the B form (6, 12, 16, 26).

Normotensive rats revealed a higher fraction of precapillary arterioles with detectable SMB expression than spontaneously hypertensive rats (SHRs) of the stroke-prone strain (26). To investigate whether this difference is of genetic origin or represents an adaptive response to chronically elevated blood pressure and cardiac hypertrophy, we determined the expression of SMB in cardiac vessels in two experimental models of hypertension-induced cardiac hypertrophy [1 clip, 1 kidney (1C1K); ANG II minipump].


    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Surgical procedures and tissue preparations. Renovascular hypertension was induced by unilateral stenosis of the left renal artery (0.22-mm silver clip) in 6-wk-old male Sprague-Dawley (SD) rats (1C1K). In matched sham-operated control animals, the renal artery was partially exposed by removal of rounding tissue. After 3 days, blood pressure was measured in the femoral artery between 9 AM and 11 AM in the freely moving animal (P23Db Statham pressure transducer, 4600 Gould pressure processor). Animals were killed 6 wk later. For continuous subcutaneous ANG II infusion, 3-mo-old male SD rats received ANG II by osmotic pump for 7 days (Alzet, model 2001, Alza) with an infusion rate of 250 ng ANG II · kg-1 · min-1. Blood pressure was measured by the tail-cuff method under light and short (2 min) ether anesthesia.

The animals were weighed and killed by cervical dislocation; the heart was quickly excised, blotted, and weighed; and the atria and right ventricles were removed. The left ventricle was immediately frozen in 2-methylbutane and stored at -80°C.

Immunofluorescence microscopy. Preparation of cryostat sections (5 µm thickness), fixation, and immunolabeling were performed as recently described (26) using a rabbit anti-SMB antibody (a25K/50K; cf. Ref. 22) and mouse anti-smooth muscle-actin antibody (aSM-actin, Boehringer, Germany). Primary antibodies were visualized as described previously (26). Nuclei were stained simultaneously by 4',6-diamidino-2-phenylindole dihydrochloride (DAPI; Sigma). Immunolabeling was evaluated with an Axioplan fluorescence microscope (Zeiss, Oberkochen, Germany) using appropriate filter systems. Micrographs were taken with an MC 100 automatic camera (Zeiss). All aSM-actin-positive and a25K/50K-positive vessels in a section were counted (2 sections/ventricle; 6 animals/group). The fraction of a25K/50K-positive vessels was expressed in percentage of vessels detected by aSM-actin staining.

Statistical evaluation. Results are expressed as means ± SE. Significance analysis was performed with the Student's t-test.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Expression of SMB was analyzed by immunofluorescence microscopy of cryostat sections of rat left ventricle using a double-labeling method (cf. Ref. 26). The specific aSM-actin antibody was used to identify cardiac vessels, and the a25K/50K antibody was used for simultaneous detection of the SMB isoform. Cardiomyocytes did not react with these antibodies (Fig. 1).


View larger version (68K):
[in this window]
[in a new window]
 
Fig. 1.   Immunofluorescence micrograph of a left rat ventricle double-labeled with a25K/50K (A) and anti-smooth muscle-actin (aSM-actin) antibodies (B). Primary antibodies were visualized with species-specific secondary antibodies conjugated with Cy3 (A) and DTAF (B). Most small vessels of ventricular tissue were labeled with both antibodies, whereas all large vessels were only labeled with the aSM-actin antibody. Arrows mark a small vessel without smooth muscle myosin heavy chain B (SMB).

In normal adult rats, the labeling pattern differs in blood vessels of different size. Most small vessels with wall thickness <13 µm and lumen diameter <18 µm of normal left ventricles were labeled with a25K/50K (Fig. 1A) and aSM-actin antibodies (Fig. 1B). Staining of nuclei with DAPI showed that the SMB-positive vessels were surrounded by a single layer of smooth muscle cells (precapillary arterioles) (not shown). Large vessels were characterized by a wall thickness of >= 13 µm and a lumen diameter of >= 18 µm. In all sections the percentage of large vessels represented barely 2% of all blood vessels. All large vessels reacted only with aSM-actin but not with a25K/50K antibody (Fig. 1B).

In another set of experiments, we compared the fraction of SMB-positive precapillary arterioles, i.e., blood vessels with wall thickness <13 µm and lumen diameter <18 µm and single smooth muscle cell layer, of the left ventricle of normotensive with experimentally hypertensive rats (1C1K and ANG II treated). Similar to control rats, only precapillary arterioles of hypertensive rats reacted with a25K/50K. The fractions of SMB-positive vessels ranged between 66.9 and 71.5% of all precapillary arterioles investigated (Table 1). This was not significantly different compared with the corresponding control animals (range 62.4-67.8%; Table 1).

                              
View this table:
[in this window]
[in a new window]
 
Table 1.   Expression of SMB in precapillary arterioles in percentage of whole precapillary arterioles of 1C1K ANG II-infused, and corresponding control rats

Blood pressure of 1C1K and ANG II animals was significantly higher (P < 0.01) compared with the corresponding controls (Tables 2 and 3). In both experimental hypertension models, heart weight and the heart-to-body weight ratio were significantly (P < 0.05) higher than the respective control rats (Tables 2 and 3).

                              
View this table:
[in this window]
[in a new window]
 
Table 2.   Mean BP, body weight, heart weight, and ratio of heart weight to body weight of 1C1K and control male rats


                              
View this table:
[in this window]
[in a new window]
 
Table 3.   Mean BP, body weight, heart weight, and ratio of heart weight to body weight of ANG II-implanted and control rats


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

In a previous study we reported a significantly lower fraction of SMB-expressing ventricular precapillary arterioles in SHRs (26). To determine whether this difference is genetically determined or represents an adaptive response to hypertension and hypertrophy, we investigated the expression of SMB in cardiac vessels in two experimental models of chronic hypertension, namely in a 1C1K model of renal artery stenosis and in an ANG II minipump model. Between 62.4 and 67.8% of cardiac precapillary arterioles expressed SMB in control SD rats. This is in accordance with recent observations in Wistar-Kyoto rats (26). Both occlusion of renal artery, which is known to activate the renin-angiotensin system, as well as chronic infusion of the vasoconstrictor ANG II, induced hypertension and cardiac hypertrophy (cf. also Refs. 4 and 9). We found no different pattern of SMB expression in precapillary arterioles in experimental hypertension (range between 66.9 and 71.5% SMB-expressing precapillary arterioles) compared with normotensive controls. Therefore, we suggest that the abnormal SMB expression pattern in ventricular precapillary arterioles of SHRs is of genetic origin rather than the result of an adaptive response to chronically enhanced blood pressure and cardiac hypertrophy.

The physiological importance of SMB expression in most of the precapillary arterioles still has to be elucidated. Interestingly, precapillary arterioles are main targets of sympathetic regulation (3, 18). In addition, smooth muscle cells of the corpus cavernosum, which are tightly innervated with sympathetic nerves, expressed high amounts of SMB (7). It seems interesting to demonstrate whether cardiac blood vessels regulate their responsiveness to sympathetic innervation by differential expression of 5'-spliced smooth muscle MyHC isoenzymes. It could be demonstrated that actin-activated ATPase activity, velocity of actin filament movements in the in vitro motility assay, attachment time in the laser trap study, as well as isometric force development and shortening velocity of SMB isoforms are higher than SMA isoforms (2, 13, 14, 22). These functional features, therefore, could confer an accelerated contractile response of SMB-expressing precapillary arterioles to sympathetic stimulation.


    ACKNOWLEDGEMENTS

The technical assistance of E. Kotitschke is gratefully acknowledged. We thank Dr. G. Lutsch for engagement and permanent help.


    FOOTNOTES

This work was supported by Deutsche Forschungsgemeinschaft Grant No. 362/16-2 to I. Morano.

Address for reprint requests and other correspondence: I. Morano, Max Delbrück Center for Molecular Medicine, Robert Rössle-Strasse 10, 13122 Berlin-Buch, Germany (E-mail: imorano{at}mdc-berlin.de).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

10.1152/ajpregu.00578.2002

Received 17 September 2002; accepted in final form 23 October 2002.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1.   Babij, P. Tissue-specific and developmentally regulated alternative splicing of a visceral isoform of smooth muscle myosin heavy chain. Nucleic Acids Res 21: 1467-1471, 1993[Abstract/Free Full Text].

2.   Babu, GJ, Loukianov E, Loukianov T, Pyne GJ, Huke S, Osol G, Low RB, Paul RJ, and Periasamy M. Loss of SMB myosin affects muscle shortening velocity and maximal force development. Nat Cell Biol 3: 1025-1029, 2001[Web of Science][Medline].

3.   Baez, LS, Feldmann SM, and Gootman PM. Central neural influence on precapillary microvessels and sphincter. Am J Physiol Heart Circ Physiol 233: H141-H147, 1977[Abstract/Free Full Text].

4.   Daemen, MJAP, Lombardi DM, Bosman FT, and Schwartz SM. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res 68: 450-456, 1991[Abstract/Free Full Text].

5.   Dickinson, CJ, and Lawrence JR. A slowly developing pressor response to small concentrations of angiotensin. Lancet 1: 1354-1356, 1963[Web of Science][Medline].

6.   DiSanto, ME, Cox RH, Wang Z, and Chacko S. NH2-terminal-inserted myosin II heavy chain is expressed in smooth muscle of small muscular arteries. Am J Physiol Cell Physiol 272: C1532-C1542, 1997[Abstract/Free Full Text].

7.   DiSanto, ME, Wang Z, Menon C, Zheng Y, Chacko T, Hypolite J, Broderick G, Wein AJ, and Chacko S. Expression of myosin isoforms in smooth muscle cells in the corpus cavernosum penis. Am J Physiol Cell Physiol 275: C976-C987, 1998[Abstract/Free Full Text].

8.   Eddinger, TJ, and Meer DP. Single rabbit stomach smooth muscle cell myosin heavy chain SMB expression and shortening velocity. Am J Physiol Cell Physiol 280: C229-C316, 2001.

9.   Griffin, SA, Brown WCB, MacPherson F, McGrath JC, Wilson VG, Korsgaard N, Mulvany MJ, and Lever AF. Angiotensin II causes vascular hypertrophy in part by non-precursor mechanism. Hypertension 17: 626-635, 1991[Abstract/Free Full Text].

10.   Hamada, Y, Yanagisawa M, Katsugarawa Y, Coleman JR, Nagata S, Matsuda G, and Masaki T. Distinct vascular, and intestinal smooth muscle myosin heavy chain mRNAs are encoded by a single-copy gene in the chicken. Biochem Biophys Res Commun 170: 53-58, 1990[Web of Science][Medline].

11.   Hypolite, JA, DiSanto ME, Zheng Y, Chang S, Wein AJ, and Chacko S. Regional variation in myosin isoforms, and phosphorylation at the resting tone in urinary bladder smooth muscle. Am J Physiol Cell Physiol 280: C254-C264, 2001[Abstract/Free Full Text].

12.   Jones, R, Steudel W, White S, Jacobsen M, and Low R. Microvessel precursor smooth muscle cells express head-inserted smooth muscle myosin heavy chain SMB isoform in hyperoxic pulmonary hypertension. Cell Tissue Res 295: 453-465, 1999[Web of Science][Medline].

13.   Kelley, CA, Takahashi M, Yu JH, and Adelstein RS. An insert of seven amino acids confers functional differences between smooth muscle myosins from the intestines and vasculature. J Biol Chem 268: 12848-12854, 1993[Abstract/Free Full Text].

14.   Lauzon, AM, Tyska MJ, Rovner AS, Freyzon Y, Warshaw DM, and Trybus KM. A 7-amino-acid insert in the heavy chain nucleotide binding loop alters the kinetics of smooth muscle myosin in the laser trap. J Muscle Res Cell Motil 19: 825-837, 1998[Web of Science][Medline].

15.   Leinwand, LA, Fournier REK, Nadal-Ginard B, and Shows TB. Isolation and characterization of human myosin heavy chain genes. Proc Natl Acad Sci USA 80: 3716-3720, 1983[Abstract/Free Full Text].

16.   Low, RB, Mitchell J, Woodcock-Mitchell J, Rovner AS, and White SL. Smooth-muscle myosin heavy-chain SMB isoform expression in developing and adult rat lung. Am J Respir Cell Mol Biol 20: 651-657, 1999[Abstract/Free Full Text].

17.   Lowey, S, and Risby D. Light chains from fast and slow muscle myosins. Nature 225: 81-85, 1971.

18.   Luff, SE, Hengstenberger SG, McLachlan EM, and Andersen WP. Distribution of sympathetic neuroeffector junctions in the juxtaglomerular region of the rabbit kidney. J Auton Nerv Syst 40: 239-252, 1992[Web of Science][Medline].

19.   Nagai, R, Kuro-o M, Babij P, and Periasamy M. Identification of two types of smooth muscle myosin heavy chain isoforms by cDNA cloning and immunoblot analysis. J Biol Chem 264: 9725-9737, 1989.

20.   Ngyuyen, H, Gubits R, Wydro R, and Nadal-Ginard B. Sarcomeric myosin heavy chain is coded by a highly conserved multigene family. Proc Natl Acad Sci USA 79: 5222-5225, 1982.

21.   Rovner, AS, Thompson MM, and Murphy RA. Two different myosin heavy chains are found in smooth muscle. Am J Physiol Cell Physiol 250: C861-C870, 1986[Abstract/Free Full Text].

22.   Rovner, A, Freyzon Y, and Trybus KM. An insert in the motor domain determines the functional properties of expressed smooth muscle myosin isoforms. J Muscle Res Cell Motil 18: 103-110, 1997[Web of Science][Medline].

23.   Somlyo, AP. Myosin isoforms in smooth muscle: how may they affect function, and structure? J Muscle Res Cell Motil 14: 557-563, 1993[Web of Science][Medline].

24.   Swynghedauw, B. Developmental and functional adaptation of contractile proteins in cardiac and skeletal muscles. Physiol Rev 66: 710-771, 1986[Abstract/Free Full Text].

25.   Szymanski, PT, Chacko TK, Rovner AS, and Goyal RJ. Differences in contractile protein content, and isoforms in phasic and tonic smooth muscles. Am J Physiol Cell Physiol 275: C684-C692, 1998[Abstract/Free Full Text].

26.   Wetzel, U, Lutsch G, Haase H, Ganten U, and Morano I. Expression of smooth muscle heavy chain B in cardiac vessels of normotensive, and hypertensive rats. Circ Res 83: 204-209, 1998[Abstract/Free Full Text].

27.   White, S, Martin A, and Periasamy M. Identification of a novel smooth muscle myosin heavy chain cDNA: isoform diversity in the S1 head region. Am J Physiol Cell Physiol 264: C1252-C1258, 1993[Abstract/Free Full Text].

28.   White, S, Zhou MY, Low RB, and Periasamy M. Myosin heavy chain isoform expression in rat smooth muscle development. Am J Physiol Cell Physiol 275: C581-C589, 1998[Abstract/Free Full Text].


Am J Physiol Regul Integr Comp Physiol 284(2):R607-R610
0363-6119/03 $5.00 Copyright © 2003 the American Physiological Society




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wetzel, K.
Right arrow Articles by Morano, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wetzel, K.
Right arrow Articles by Morano, I.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online